跳至主要内容
临床试验/RBR-9zpc27
RBR-9zpc27尚未招募3 期

Cocaine and crack Addiction Treatment with Ibogaine - CATI: Cocaine Addiction Treatment Ibogaine

Instituto Veracruz de Pesquisa e Tratamento da Dependência Química Ltda.0 个研究点开始时间: 2017年12月11日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 50Y(—)

入选标准

  • Age between 18 and 50 years; complete primary education; absence of abnormalities in the evaluation of hemogram, transaminases, gamma-GT, glycemia, hepatitis C, HIV serology, Beta HCG for women, sodium, potassium, magnesium and electrocardiogram with a report attesting the absence of any abnormalities, including prolongation of the QT interval ; cocaine and / or crack dependence, with at least one unsuccessful attempt at treatment; perspective of return to family life; maintenance of abstinence from psychoactive drugs for 30 days between the initial evaluation and the medication session (ascertained by personal reporting and urinalysis of urine at all psychological visits and the day the drug is received); interruption of the use of antidepressants and mood stabilizers, under the guidance of the clinician responsible

排除标准

  • Psychotic disorder; schizophrenia and any other psychiatric disorder in which you are in crisis; exams beyond normality; prolonged QT interval demonstrated on the electrocardiogram; pregnancy and breastfeeding; large surgeries in the last 6 months; uncontrolled arterial hypertension; uncontrolled diabetes; myocardial infarction and ventricular arrhythmias; hepatic insufficiency; previous history of accidents with head trauma and loss of consciousness; Alzheimer's disease; Parkinson's disease; Being a carrier of epilepsy; motor difficulties that may interfere with writing ability; do not be abstinent from psychoactive drugs for 30 days on the day you receive the drug treatment; be under the influence of antidepressants and mood stabilizing medications.

研究者

发起方
Instituto Veracruz de Pesquisa e Tratamento da Dependência Química Ltda.

相似试验

已完成
不适用
The Efficacy of Ibogaine in the Treatment of Addiction; an open label, single fixed dose pilot-study of the efficacy of ibogaine in opiod-dependent subjectsopioid addictionopioid dependence10021563
NL-OMON40645niversitair Medisch Centrum Sint Radboud12
进行中(未招募)
1 期
The Efficacy of Ibogaine in the Treatment of Addiction; an non-controlled, non-blind study , on the effect of a single dose of ibogaine in opioid-dependent subjectsDependence on opiate narcotics
EUCTR2014-000354-11-NLRadboud UMC12
终止
1 期
A Novel Therapy for cocaine dependence during abstinence: A randomized clinical trialThe inclusion criteria for participation in this study were: 1) having the respective age between 18 and 31&#442) History of one months of cocaine avoidance&#44and 3) having at least the educational levelTopiramate&#44Contingency Management&#44Craving&#44Anticonvulsants/adverse effects&#44Pharmacotherapy&#44Cocaine Dependence
TCTR20170112001non100
已完成
1 期
Two New Therapies in the Cocaine-dependents, Comparison of Topiramate and Contingency Management, a Single-centerAll stages of the research were performed after obtaining informed written consent from the parents and the verbal consent of the child and based on the latest version of Helsinki Declaration.Topiramate&#44Contingency Management&#44Cocainen&#44craving
TCTR20180926002none100
已完成
不适用
Treating cocaine dependence by targeting underlying cognitive processescocaïnemisbruik en cocaïneafhankelijkheidcocaine dependenceaddiction
NL-OMON41639Academisch Medisch Centrum50